← FDA DRUG APPROVALS

FDA BLA · BLA761146

QWO

Sponsor: ENDO GLOBAL AESTHETICS LTD

APPLICATION
BLA761146
TYPE
BLA
ORIGINAL APPROVAL
2020-07-06
LATEST ACTION
2020-07-06
ROUTE
SUBCUTANEOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

QWOPrescription
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES 1.84MG/VIAL · SOLUTION · SUBCUTANEOUS
QWOPrescription
COLLAGENASE CLOSTRIDIUM HISTOLYTICUM-AAES 0.92MG/VIAL · SOLUTION · SUBCUTANEOUS

Approval history

2020-07-06TYPE 10- BLA · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Biologics industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →